DiscovereClinicalMedicine in conversation withGiulia Zamagni on the disease burden estimates and temporal trends from 1990 to 2023 for leukemia, multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma in Italy
Giulia Zamagni on the disease burden estimates and temporal trends from 1990 to 2023 for leukemia, multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma in Italy

Giulia Zamagni on the disease burden estimates and temporal trends from 1990 to 2023 for leukemia, multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma in Italy

Update: 2025-10-13
Share

Description

Giulia Zamagni joins Claudia Schaefer to discuss her recent Series of 4 papers from the Italian Global Burden of Disease collaborators providing the disease burden estimates and temporal trends for leukemia, multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma in Italy.

Click here to read the full text in this series: paper 1; paper 2; paper 3; paper 4 


Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Giulia Zamagni on the disease burden estimates and temporal trends from 1990 to 2023 for leukemia, multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma in Italy

Giulia Zamagni on the disease burden estimates and temporal trends from 1990 to 2023 for leukemia, multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma in Italy

The Lancet Group